Patents by Inventor James Michael McGill

James Michael McGill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of primary biliary cholangitis and primary sclerosing cholangitis with baricitinib
    Patent number: 11197860
    Abstract: Methods of treating Primary Biliary Cholangitis and/or Primary Sclerosing Cholangitis with baricitinib, including formulations and dose regimens. The amount of baricitinib may be administered as a 4 mg tablet or pill that includes one or more excipients. The amount of baricitinib may be administered daily or at some other frequency.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: December 14, 2021
    Assignee: Eli Lilly and Company
    Inventors: Patrick L McCollam, James Michael McGill, Ana Luisa de Macedo Pinto Correia
  • Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis with Baricitinib
    Publication number: 20200121685
    Abstract: Methods of treating Primary Biliary Cholangitis and/or Primary Sclerosing Cholangitis with baricitinib, including formulations and dose regimens. The amount of baricitinib may be administered as a 4 mg tablet or pill that includes one or more excipients. The amount of baricitinib may be administered daily or at some other frequency.
    Type: Application
    Filed: October 10, 2019
    Publication date: April 23, 2020
    Applicant: Eli Lilly and Company
    Inventors: Patrick L. McCollam, James Michael McGill, Ana Luisa de Macedo Pinto Correia